Chinese english Germany Japanese Korea

17-(β-D-Glucopyranosyloxy)kaurane-3β,16α-diol

17-(β-D-Glucopyranosyloxy)kaurane-3β,16α-diol Struktur
133740-37-1
CAS-Nr.
133740-37-1
Englisch Name:
17-(β-D-Glucopyranosyloxy)kaurane-3β,16α-diol
Synonyma:
Suavioside A;17-(β-D-Glucopyranosyloxy)kaurane-3β,16α-diol;β-D-Glucopyranoside, (3β)-3,16-dihydroxykauran-17-yl
CBNumber:
CB62136592
Summenformel:
C26H44O8
Molgewicht:
484.62276
MOL-Datei:
133740-37-1.mol
Request For Quotation

17-(β-D-Glucopyranosyloxy)kaurane-3β,16α-diol Eigenschaften

Siedepunkt:
661.0±55.0 °C(Predicted)
Dichte
1.33±0.1 g/cm3(Predicted)
pka
12.94±0.70(Predicted)

Sicherheit

17-(β-D-Glucopyranosyloxy)kaurane-3β,16α-diol Chemische Eigenschaften,Einsatz,Produktion Methoden

17-(β-D-Glucopyranosyloxy)kaurane-3β,16α-diol Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

17-(β-D-Glucopyranosyloxy)kaurane-3β,16α-diol Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 9)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
BOC Sciences 		+1-631-485-4226
inquiry@bocsci.com United States 19553 58
TargetMol Chemicals Inc. 		+1-781-999-5354
support@targetmol.com United States 19973 58
BioBioPha Co., Ltd. 0871-65217109 13211707573;
 y.liu@mail.biobiopha.com China 5654 65
Sichuan Wei Keqi Biological Technology Co., Ltd. 028-81700200 18116577057
 3003855609@qq.com China 7887 56
Shanghai YuanYe Biotechnology Co., Ltd. 021-61312847; 18021002903
 3008007409@qq.com China 27314 60
Shanghai Bohu Biotechnology Co., LTD 021-57763112 13585886131
 3004987436@qq.com China 9694 58
Beijing PUXI Standard Technology Co., Ltd. 400-808-7372 13161114455;
 info@rmuu.com China 4990 58
Shanghai Moqi Biological Technology Co., LTD 021-38218169 13341702378
 190129269@qq.com China 9118 58

133740-37-1()Verwandte Suche:

Stigmast-5-en-3-β-ol p-Menth-1-en-8-ol
  • 17-(β-D-Glucopyranosyloxy)kaurane-3β,16α-diol
  • Suavioside A
  • β-D-Glucopyranoside, (3β)-3,16-dihydroxykauran-17-yl
  • 133740-37-1
Copyright 2019 © ChemicalBook. All rights reserved